Northern Financial Advisors Inc Pfizer Inc Transaction History

Northern Financial Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $376,768 - $440,404	-11,741 Reduced 58.86%	8,208 $272 Million
Q2 2023 Jul 21, 2023	SELL	$36.12 - $41.79 $79,464 - $91,938	-2,200 Reduced 9.93%	19,949 $732 Million
Q1 2023 Apr 26, 2023	BUY	$39.39 - $51.28 $93,551 - $121,790	2,375 Added 12.01%	22,149 $904 Million
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $825,564 - $1.08 Million	19,774 New	19,774 $1.01 Billion

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Northern Financial Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Northern Financial Advisors Inc with notifications on news.